Who
Barry D. Michaels
Director
Company insider
Files Form 4 as: Director, Zynex; Chief Financial Officer, VivoSim Labs.
In numbers
- Trades disclosed
- 43
- Buys
- 2
- Sells
- 3
- Bought
- $20K
- Sold
- $887K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 16 Mar 2012
- Last trade
- 26 Mar 2026
- Last filed
- 27 Mar 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Mar 2026filed 27 Mar 2026 | ZynexMedical Devices | SEC FORM 4 Code D | —80,001 at $0.00 | filing |
| 26 Mar 2026filed 27 Mar 2026 | Zynex | SEC FORM 4 Code D | —80,001 at $0.00 | filing |
| 15 May 2025filed 16 May 2025 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 16 May 2024filed 17 May 2024 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 15 Jun 2023filed 16 Jun 2023 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Jun 2022filed 2 Jun 2022 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 16 Jul 2021filed 19 Jul 2021 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 29 Jul 2020filed 30 Jul 2020 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 29 Jul 2020filed 30 Jul 2020 | Zynex | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 31 Aug 2015filed 11 May 2016 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code G | —86,808 at $0.00 | filing |
| 24 Aug 2015filed 24 Aug 2015 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code F | $234K100,692 at $2.32 | filing |
| 24 Aug 2015filed 24 Aug 2015 | VIVS VivoSim Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,692 at $0.00 | filing |
| 4 Jun 2015filed 8 Jun 2015 | VIVS VivoSim Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —255,000 at $0.00 | filing |
| 30 Dec 2014filed 31 Dec 2014 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Sold | $79K10,500 at $7.50 | filing |
| 29 Dec 2014filed 31 Dec 2014 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Sold | $34K4,500 at $7.50 | filing |
| 11 Sep 2014filed 31 Dec 2014 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code G | —300,646 at $0.00 | filing |
| 26 Aug 2014filed 28 Aug 2014 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code M | $30K13,157 at $2.25 | filing |
| 26 Aug 2014filed 28 Aug 2014 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code M | $21K5,317 at $3.93 | filing |
| 26 Aug 2014filed 28 Aug 2014 | VIVS VivoSim Labsoption or derivative · Biotechnology | SEC FORM 4 Code M | —13,157 at $0.00 | filing |
| 26 Aug 2014filed 28 Aug 2014 | VIVS VivoSim Labsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,317 at $0.00 | filing |
News
VivoSim Labs Celebrates Updated FDA Regulations Allowing Greater use of Non-Animal Testing MethodsVIVS · owensoundsuntimes.com · 7 Oct 2026
0 headlines in the last 90 days name Barry D. Michaels; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.